ストックスクリーナーアプリを入手
80.90
0.46%
-0.37
アフターアワーズ：
80.90
前日終値:
$81.27
開ける：
$80.72
24時間の取引高:
572.06K
Relative Volume:
0.92
時価総額：
$4.46B
収益：
$1.43B
当期純損益:
$107.13M
株価収益率:
41.76
EPS:
1.9372
ネットキャッシュフロー:
$161.04M
1週間 パフォーマンス:
+4.28%
1か月 パフォーマンス:
+4.85%
6か月 パフォーマンス:
+24.18%
1年 パフォーマンス:
+48.58%
1日の値動き範囲:
$80.33
$81.77
1週間の範囲:
$77.39
$81.77
52週間の値動き範囲:
$48.82
$85.76
Livanova Plc Stock (LIVN) Company Profile
Compare LIVN vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
80.90 | 4.46B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-10-07 | 開始されました | Barclays | Overweight |
| 2025-12-19 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-20 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 開始されました | Goldman | Buy |
| 2024-09-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 繰り返されました | Needham | Buy |
| 2024-02-20 | アップグレード | Mizuho | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-04-14 | 開始されました | Mizuho | Neutral |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-02-24 | アップグレード | UBS | Neutral → Buy |
| 2021-12-03 | 開始されました | Goldman | Buy |
| 2021-08-20 | 繰り返されました | Needham | Buy |
| 2021-07-20 | アップグレード | Needham | Hold → Buy |
| 2021-03-03 | ダウングレード | Berenberg | Buy → Hold |
| 2021-01-05 | ダウングレード | Needham | Buy → Hold |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-06-26 | 繰り返されました | Needham | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-08 | 開始されました | Stifel | Buy |
| 2018-05-31 | 繰り返されました | Needham | Buy |
| 2018-02-28 | 繰り返されました | Needham | Buy |
すべてを表示
Livanova Plc (LIVN) 最新ニュース
Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsight - GlobeNewswire Inc.
Chief legal officer at LivaNova (LIVN) awarded 6,291 stock units vesting through 2029 - Stock Titan
Understanding Momentum Shifts in (LIVN) - Stock Traders Daily
LivaNova Director Sells 1,650 Shares for $131,500 - The Motley Fool
LivaNova (NASDAQ: LIVN) officer plans 3,500-share sale from 2026 stock award vesting - Stock Titan
Director at LivaNova (LIVN) sells 3,500 shares in open-market trade - Stock Titan
LivaNova (LIVN) Falls 1.64% to $79.38, Hovering at the Middle of Its Trading RangeSwing Entry Signals - siam.in
LivaNova PLC (NASDAQ:LIVN) Combines Strong Growth With a Timely Technical Setup - ChartMill
Director at LivaNova (NASDAQ: LIVN) sells 2,300 shares - Stock Titan
LivaNova (NASDAQ:LIVN) Combines Growth and Reasonable Valuation - ChartMill
LivaNova (NASDAQ: LIVN) executive plans stock sale - Stock Titan
LivaNova (LIVN) Declines 1.5% to $81.13 Amid Medical Device Sector CautionDiagonal Spread Trade - vinanet.vn
LivaNova (LIVN) Director Francesco Bianchi Sells 1,650 Shares - GuruFocus
LivaNova (LIVN) Director Francesco Bianchi Sells 1,650 Shares - GuruFocus
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September - finance.yahoo.com
LivaNova stock gains as Piper Sandler raises price target on strong Q2 results - ad-hoc-news.de
LivaNova (NASDAQ: LIVN) officer lines up six-figure stock sale - Stock Titan
LivaNova PLC (LIVN) director sells 1,650 shares - Stock Titan
LIVN Reiterated by Piper Sandler -- Price Target Raised to $90 - GuruFocus
Piper Sandler raises Livanova stock price target on cardiopulmonary growth outlook - Investing.com
LivaNova stock holds near 80 USD as investors digest latest earnings and ownership shift - ad-hoc-news.de
(LIVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
LivaNova (NASDAQ: LIVN) officer to sell 1,650 shares - Stock Titan
LivaNova: Quantitative Stock of the Week - Barron's
Is LivaNova (LIVN) Fairly Valued As Growth Hopes Meet Reimbursement Risks? - sahmcapital.com
LivaNova: Careful About The Valuation And Upside (NASDAQ:LIVN) - Seeking Alpha
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move - vinanet.vn
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move - dars.gov.et
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move: Shares Finish 0.61% Down in the Available RecordRevenue Growth Report - dars.gov.et
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move: Shares Finish 0.61% Down in the Available RecordTech Earnings Analysis - www.dars.gov.et
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionOne-Time Gain Impact - dars.gov.et
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionEarnings Manipulation Risk - vinanet.vn
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionSegment Revenue Breakdown - dars.gov.et
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionBook Value Growth - dars.gov.et
LIVN Looks 23.4% Overvalued on GF Value™ - GuruFocus
LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to "Hold" - MarketBeat
LivaNova PLC (LIVN) Stock Down 3.3% but Still Overvalued -- GF S - GuruFocus
Anne Liddy Joins LivaNova as Chief Legal Officer - Medical Product Outsourcing
LivaNova (NASDAQ:LIVN) Gains Attention After Strong Results - Kalkine Media
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseCall Wall - dars.gov.et
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseDip Buy Trade - vinanet.vn
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordAnalyst Consensus Shift - dars.gov.et
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordNegative Surprise Momentum - Vinanet
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup - ChartMill
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseVolatility Skew - siam.in
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseBuyback Factor - dars.gov.et
LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE - MarketBeat
Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock - Benzinga
LivaNova CIO Ahmet Tezel Reports Stock Transactions and Ownership Update - Kalkine Media
Livanova Plc (LIVN) 財務データ
収益
当期純利益
現金流量
EPS
Livanova Plc (LIVN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Bianchi Francesco | Officer |
Sep 10 '26 |
Proposed Sale |
78.01 |
3,500 |
273,032 |
0 |
| Story Brooke | Director |
Sep 04 '26 |
Sale |
81.42 |
2,300 |
187,270 |
7,488 |
| Story Brooke | Officer |
Sep 04 '26 |
Proposed Sale |
81.42 |
2,300 |
187,270 |
0 |
| Poletti Franco | Officer |
Sep 02 '26 |
Proposed Sale |
82.09 |
10,755 |
882,888 |
0 |
| Bianchi Francesco | Director |
Aug 31 '26 |
Sale |
79.72 |
1,650 |
131,538 |
7,934 |
| Bianchi Francesco | Officer |
Aug 31 '26 |
Proposed Sale |
79.72 |
1,650 |
131,538 |
0 |
| Tezel Ahmet | Officer |
Aug 11 '26 |
Proposed Sale |
78.48 |
2,675 |
209,942 |
0 |
| Tezel Ahmet | Chief Innovation Officer |
Aug 11 '26 |
Sale |
77.74 |
2,675 |
207,942 |
6,090 |
| Tezel Ahmet | Chief Innovation Officer |
Aug 11 '26 |
Option Exercise |
52.68 |
12,692 |
668,615 |
18,782 |
| Story Brooke | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
10,274 |
0.02%
1.36%
大文字化:
|
ボリューム (24 時間):